Angiodynamics Overview

  • Founded

  • 1988

Founded
  • Status

  • Public

  • Employees

  • 902

Employees
  • Stock Symbol

  • ANGO

Stock Symbol
  • Investments

  • 15

  • Share Price

  • $12.47

  • (As of Wednesday Closing)

Angiodynamics General Information

Description

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, it derives a majority of revenue from the United States.

Contact Information

Website
www.angiodynamics.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • 14 Plaza Drive
  • Latham
  • New York, NY 12110
  • United States
+1 (518) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiodynamics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.47 $12.40 $11.33 - $24.87 $488M 39.1M 329K -$0.84

Angiodynamics Financials Summary

In Thousands,
USD 		TTM 30-Nov-2022 FY 2022 31-May-2022 FY 2021 31-May-2021 FY 2020 31-May-2020
EV 531,679 762,363 857,267 372,933
Revenue 327,934 316,219 291,010 264,157
EBITDA (3,412) 88 (9,275) (143,423)
Net Income (32,714) (26,547) (31,548) (166,787)
Total Assets 558,207 552,751 561,438 594,214
Total Debt 49,796 33,783 20,000 40,836
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angiodynamics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthca
Surgical Devices
New York, NY
902 As of 2022
000.00
000000 - 000 000.00

00000

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut lab
00000000 0000000
Irvine, CA
0000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
00000 0000000 000 00
Santa Clara, CA
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angiodynamics Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inari Medical Formerly VC-backed Irvine, CA 0000 00000 00000000 00000
000000000 0000000 Formerly VC-backed Santa Clara, CA 0000 00000 000000000 00000
00000000 Formerly VC-backed Alameda, CA 0000 0000 00000000 0000
000000 Corporation Marietta, GA 000 00000 000000000 00000
0000000 Venture Capital-Backed Naples, FL 0000 00000 0000000000 0 00000
You’re viewing 5 of 42 competitors. Get the full list »

Angiodynamics Patents

  • 1,125

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 119

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Angiodynamics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230030606-A1 Device and method of use for aspiration system retrievers Pending 20-Jul-2021 0000000000
US-D972723-S1 Reinforcement arms and collar for an expandable cannula tip Active 17-Mar-2021 00
US-D972720-S1 Port for aspiration device Active 04-Feb-2021 00
US-11612734-B2 Method to secure an elastic component in a valve Active 08-Dec-2020 000000000 000
US-20210315639-A1 Current analysis for patient customized irreversible electroporation treatment planning Pending 13-Apr-2020 A61B34/10
To view Angiodynamics’s complete patent history, request access »

Angiodynamics Executive Team (18)

Name Title Board Seat Contact Info
James Clemmer Chief Executive Officer & Board Member
Stephen Trowbridge Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Laura Piccinini General Manager & Senior Vice President
Chad Campbell Senior Vice President and General Manager, Vascular Access
Scott Centea Senior Vice President and General Manager, VIT
You’re viewing 5 of 18 executive team members. Get the full list »

Angiodynamics Board Members (11)

Name Representing Role Since
000000 000000 Angiodynamics Board Member, Chairman of the Audit Committee and Member of the Compensation Committee 000 0000
000000 0000 Angiodynamics Board Member 000 0000
000000 00000000 Angiodynamics Chairman of the Board 000 0000
00000 0000000 Angiodynamics Chief Executive Officer & Board Member 000 0000
000 0000 Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Angiodynamics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiodynamics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Investments & Acquisitions (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000000 (0 27-Jul-2021 000000000 000 Buildings and Property
0000000 (00 0 17-Dec-2020 000000000 0000 Buildings and Property 00000 000
00000 02-Oct-2019 0000000000 000.00 Surgical Devices 00000 000
000000000 21-Sep-2018 0000000000 0000 Therapeutic Devices 00000 000
Surgical Specialties (BioSentry Tract Sealant System) 14-Aug-2018 Corporate Asset Purchase 000.00 Other Devices and Supplies 00000 000
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Angiodynamics Subsidiaries (1)

Company Name Industry Location Founded
000000 Surgical Devices Andover, MA 0000
To view Angiodynamics’s complete subsidiaries history, request access »

Angiodynamics ESG

Risk Overview

Risk Rating

Updated November, 23, 2022

28.96 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,231

Rank

00.00

Percentile

Healthcare

Industry

00 of 601

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 207

Rank

00.00

Percentile

To view Angiodynamics’s complete esg history, request access »

Angiodynamics Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 (000000000000 10-Mar-2016 000000000 00000 00 Completed
  • 0000000000000
0000000000 01-Apr-2015 000000000 000 Completed
  • 0000000000000
AngioCare 01-Jan-2011 Merger/Acquisition Completed
To view Angiodynamics’s complete exits history, request access »